These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3158448

  • 21. Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: therapeutic and endocrine effects in postmenopausal advanced breast cancer patients.
    Gasparini G, Canobbio L, Galligioni E, Fassio T, Brema F, Crivellari D, Villalta D, Di Fronzo G, Talamini R, Monfardini S.
    Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1451-9. PubMed ID: 2960532
    [Abstract] [Full Text] [Related]

  • 22. Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report.
    Trodella L, Ausilli-Cefaro GP, Turriziani A, Saccheri S, Venturo I, Minotti G.
    Am J Clin Oncol; 1982 Oct; 5(5):495-9. PubMed ID: 6217741
    [No Abstract] [Full Text] [Related]

  • 23. [Sequential therapy with antiestrogens and progestational drugs in carcinoma of the breast in an advanced stage].
    Palmeri R, Papalia E, Lazzara S, Belnome NA, Gorgone S, Calbo E, Melita P.
    Chir Ital; 1987 Apr; 39(2):185-92. PubMed ID: 2958166
    [Abstract] [Full Text] [Related]

  • 24. [High dose medroxyprogesterone acetate in metastatic breast cancer. Comparative clinical, pharmacokinetic and pharmacodynamic data of different forms of administration].
    Blossey HC, Wander HE, Nagel GA, Köbberling J, Kleeberg U.
    Onkologie; 1982 Aug; 5 Suppl():13-6. PubMed ID: 6215599
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Oral route administration of medroxyprogesterone acetate (MAP) at high doses in the treatment of advanced breast cancer: clinical results.
    Guarnieri A, Tucci E, D'Aniello C, Carli A, Mariani L, De Stefano A, Nardi P.
    Chemioterapia; 1984 Oct; 3(5):320-3. PubMed ID: 6241848
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate.
    Halpenny O, Bye A, Cranny A, Feely J, Daly PA.
    Med Oncol Tumor Pharmacother; 1990 Oct; 7(4):241-7. PubMed ID: 2149401
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
    Vavra N, Salzer H, Sevelda P, Breitenecker G, Czerwenka K, Kucera H.
    Gynakol Rundsch; 1990 Oct; 30(3):133-43. PubMed ID: 2147161
    [Abstract] [Full Text] [Related]

  • 34. [Combination chemotherapy using low-dose epirubicin and vindesine in patients with metastatic breast cancer].
    Takatsuka Y, Nakayama H, Kawahara T.
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):667-71. PubMed ID: 2965547
    [Abstract] [Full Text] [Related]

  • 35. Cyclic hormonal treatment in ovarian cancer. A phase-II trial.
    Jakobsen A, Bertelsen K, Sell A.
    Eur J Cancer Clin Oncol; 1987 Jul; 23(7):915-6. PubMed ID: 2959486
    [Abstract] [Full Text] [Related]

  • 36. [Chemo-endocrine therapy of advanced breast cancer].
    Nomura Y.
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3214-20. PubMed ID: 2973769
    [Abstract] [Full Text] [Related]

  • 37. [Metastatic breast cancer: controlled treatment trial of chemotherapy combined with hormone therapy using medroxyprogesterone alone or combined with tamoxifen].
    Jouve M, Palangie T, Bretaudeau B, Garcia-Giralt E, Asselain B, Magdelenat H, Pouillart P.
    Bull Cancer; 1984 Dec; 71(2):148. PubMed ID: 6733294
    [No Abstract] [Full Text] [Related]

  • 38. Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate: its correlation with serum cortisol.
    Van Deijk WA, Blijham GH, Mellink WA, Meulenberg PM.
    Cancer Treat Rep; 1985 Jan; 69(1):85-90. PubMed ID: 3155651
    [Abstract] [Full Text] [Related]

  • 39. Medroxyprogesterone acetate versus tamoxifen in the therapy of advanced breast cancer.
    Lorenz I, Mechl Z.
    Neoplasma; 1985 Jan; 32(1):119-24. PubMed ID: 3157070
    [Abstract] [Full Text] [Related]

  • 40. On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.
    Petru E, Schmähl D.
    Klin Wochenschr; 1987 Oct 15; 65(20):959-66. PubMed ID: 2963170
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.